In Vivo Genetic Eye Disease Correction Using Split AAV-Mediated Adenine Base Editing

被引：0
|
作者：
Sullivan, Jack [1 ]
Muller, Alissa [2 ,3 ]
Schwarzer, Wibke [2 ,3 ]
Wang, Mantian [2 ,3 ]
Park-Windhol, Cindy [1 ]
Hasler, Pascal [3 ]
Moreau, Pierre-Henri [4 ]
Azoulay, Thierry [5 ]
Janeschitz-Kriegl, Lucas [2 ,3 ]
Szabo, Arnold [6 ]
Scholl, Hendrik P. N. [2 ,3 ]
Roska, Botond [2 ,3 ]
Gyorgy, Bence [2 ,3 ]
Bryson, David I. [1 ]
Ciaramella, Giuseppe [1 ]
机构：
[1] Beam Therapeut, Cambridge, MA USA
[2] Inst Mol & Clin Ophthalmol Basel, Basel, Switzerland
[3] Univ Basel, Dept Ophthalmol, Basel, Switzerland
[4] Univ Strasbourg, SILABE, Niederhausbergen, France
[5] Clin Vet Agoravet, Strasbourg, France
[6] Semmelweis Univ, Dept Anat, Budapest, Hungary
来源：
MOLECULAR THERAPY | 2023年 / 31卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
308
引用
收藏
页码：168 / 168
页数：1
相关论文
共 50 条
  • [31] AAV-mediated in vivo knockdown of luciferase using combinatorial RNAi and U1i
    Koornneef, A.
    van Logtenstein, R.
    Timmermans, E.
    Pisas, L.
    Blits, B.
    Abad, X.
    Fortes, P.
    Petry, H.
    Konstantinova, P.
    Ritsema, T.
    GENE THERAPY, 2011, 18 (09) : 929 - 935
  • [32] AAV-mediated knockdown of Peripherin-2 in vivo using miRNA-based hairpins
    A Georgiadis
    M Tschernutter
    J W B Bainbridge
    S J Robbie
    J McIntosh
    A C Nathwani
    A J Smith
    R R Ali
    Gene Therapy, 2010, 17 : 486 - 493
  • [33] Long-term correction of canine FVII deficiency using AAV-mediated expression of zymogen FVII
    Marcos-Contreras, O. A.
    Smith, S. M.
    Bellinger, D. A.
    Merricks, E.
    Faella, A.
    Pavani, G.
    Zhou, S.
    Nichols, T. C.
    High, K. A.
    Margaritis, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 162 - 162
  • [34] AAV-mediated in vivo knock-down of luciferase using RNAi and U1i
    Koornneef, A.
    van Logtenstein, R.
    Timmermans, E.
    Pisas, L.
    Blits, B.
    Abad, X.
    Fortes, P.
    Petry, H.
    Konstantinova, P.
    Ritsema, T.
    HUMAN GENE THERAPY, 2010, 21 (10) : 1443 - 1444
  • [35] Publisher Correction: Precision genome editing using cytosine and adenine base editors in mammalian cells
    Tony P. Huang
    Gregory A. Newby
    David R. Liu
    Nature Protocols, 2021, 16 : 5740 - 5740
  • [36] In vivo correction of a metabolic liver disease by AAV8-mediated homologous recombination
    Wursthorn, Karsten
    Storm, Terry
    Kay, Mark
    Feingold, Milton
    Grompe, Markus
    HEPATOLOGY, 2006, 44 (04) : 433A - 433A
  • [37] In Vivo Correction of a Metabolic Liver Disease by AAV8-Mediated Homologous Recombination
    Wursthorn, Karsten
    Storm, Terry
    Kay, Mark A.
    Finegold, Milton
    Grompe, Markus
    MOLECULAR THERAPY, 2006, 13 : S311 - S312
  • [38] EFFICIENT CORRECTION HUTCHINSON-GILFORD PROGERIA SYNDROME MUTATION IN IPSC USING ADENINE BASE EDITING
    Asensi, K. D.
    Rodrigues, K. P. M.
    Castro, G. F.
    de Figueiredo, A. F.
    Campos, D. B. P.
    Pereira, J. P.
    Kasai-Brunswick, T. H.
    de Carvalho, A. C. Campo
    CYTOTHERAPY, 2022, 24 (10) : S14 - S14
  • [39] Silencing Huntingtin in the hypothalamus of a transgenic Huntington disease rat model using AAV-mediated microRNA strategy
    Stricker-Shaver, J.
    Fabry, B. T.
    Yu-Taeger, L.
    Stanek, L.
    Calaminus, C.
    Pichler, B. J.
    Shihabuddin, L. S.
    Riess, O.
    Nguyen, H. P.
    HUMAN GENE THERAPY, 2018, 29 (12) : A102 - A103
  • [40] Genetic and functional correction of argininosuccinate lyase deficiency using CRISPR adenine base editors
    Jalil, Sami
    Keskinen, Timo
    Juutila, Juhana
    Maldonado, Rocio Sartori
    Euro, Liliya
    Suomalainen, Anu
    Lapatto, Risto
    Kuuluvainen, Emilia
    Hietakangas, Ville
    Otonkoski, Timo
    Hyvonen, Mervi E.
    Wartiovaara, Kirmo
    AMERICAN JOURNAL OF HUMAN GENETICS, 2024, 111 (04) : 714 - 728
12345